Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Amines Stories

2013-09-25 08:29:43

Offers More Than 20 Million Female Sufferers Newfound Sense of Control over Condition WHITEHOUSE STATION, N.J., Sept. 25, 2013 /PRNewswire/ -- Merck Consumer Care, the makers of OXYTROL FOR WOMEN, announced today that the more than 20 million women suffering from overactive bladder (OAB) can now gain better control of their condition with a visit to the feminine care aisle at their local retailer. OXYTROL FOR WOMEN is a thin, flexible patch that is discreetly applied to the abdomen,...

2013-09-23 08:28:52

NASDAQ: CRME   TSX: COM VANCOUVER, Sept. 23, 2013 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced publication of positive data from an open label study in patients with atrial fibrillation that compared treatment with vernakalant intravenous (IV) to oral propafenone and oral flecainide. Patients treated with vernakalant achieved conversion to normal sinus rhythm in a median time of 12 minutes compared to 151 minutes for the propafenone group and...

2013-09-17 16:24:16

CHICAGO, Sept. 17, 2013 /PRNewswire-USNewswire/ -- The physicians of the American Academy of Pain Medicine (AAPM) hailed long-awaited labeling changes and other steps taken by the U.S. Food and Drug Administration (FDA) last week to enhance safety in the prescribing of extended-release and long-acting (ER/LA) opioids. AAPM further supported the Agency's decision to deny portions of a citizen petition seeking dosage and treatment duration limits that would have applied to every patient...

2013-09-16 08:28:12

Relmada Therapeutics announces that has retained the Malvern Consulting Group as advisor for the development of d-methadone for diabetic painful neuropathy (DPN). NEW YORK, Sept 16, 2013 /PRNewswire/ -- Relmada Therapeutics Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced that has signed a collaboration agreement with the Malvern Consulting Group as clinical and regulatory advisor. "We are particularly pleased about this...

2013-09-12 08:31:21

Two lead programs to enter pivotal trials MALVERN, Pa., Sept. 12, 2013 /PRNewswire/ -- Egalet Ltd., a specialty pharmaceutical company developing and planning to commercialize abuse-deterrent oral products for the treatment of pain and other indications, announced today that it has closed a financing of up to $20 million led by Index Ventures with participation from other existing investors. Egalet has received $10 million initially, with an option for an additional $10 million...

2013-09-06 23:21:30

Edmonton Alberta dentist Dr. Christine Fialka-Eshenko is proud to announce she has been elected to the Legacy Project Chair of Edmonton and District Dental Society. Edmonton, AB (PRWEB) September 06, 2013 Edmonton Alberta dentist Dr. Christine Fialka-Eshenko, founder of the prominent dental practice Focus on Smiles, is proud to announce she has been appointed to the Project Chair of Edmonton and District Dental Society (EDDS.) EDDS is also celebrating 100 years of service. Dr....

2013-08-30 23:19:39

It is estimated that over 100,000,000 Americans currently live with chronic pain or frequently recurring pain. That is why Medication Discount Card LLC is offering Tramadol Discount Cards. (PRWEB) August 30, 2013 It is estimated that over 100,000,000 Americans currently live with chronic pain or frequently recurring pain. This can significantly impede productivity and quality of life, rendering sufferers unable to care for themselves or their children or to get and keep a job. It can...

2013-08-29 12:26:31

TORONTO, Aug. 29, 2013 /CNW/ - UCB Canada Inc. announced today that NEUPRO® (rotigotine) is now available in Canada for the treatment of Parkinson's disease. The availability of NEUPRO® in Canada follows Health Canada's approval in March, making it the first new treatment for Parkinson's disease approved in Canada in five years.  NEUPRO® is the first and only non-ergolinic dopamine agonist available in a patch, and provides 24-hour delivery of rotigotine through the skin...

2013-08-21 23:20:46

Cultivation approval from USDA - mid-decade launch planned with a new mode of action: tolerance to isoxaflutole and glyphosate herbicides Research Triangle Park, N.C. (PRWEB) August 21, 2013 Bayer CropScience and MS Technologies LLC have achieved a milestone on their path to delivering new solutions for soybean farmers. The dual herbicide tolerance trait Balance™ GT (Event FG72) has received cultivation approval from the U.S. Department of Agriculture (USDA). This step follows approval...

2013-08-21 08:26:19

ATLANTA, Aug. 21, 2013 /PRNewswire/ -- Atlantic Pharmaceuticals, Inc., today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 8,507,001 that contains claims which cover Atlantic's SMART/Script(TM) abuse deterrent drug delivery system. SMART/Script(TM) is designed to prevent dose dumping of orally delivered prescription opioids and may sequester and reduce drug release of a pharmaceutical that has been subjected to a variety of physical...